Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

AIM-IBD: A Microbiome-Targeted Supplement in Mild-to-Moderate Ulcerative Colitis

ENBIOSIS BIOTECHNOLOGIES · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
gut-microbiotainflammatory-bowel-diseasemicrobiomeulcerative-colitis
ulcerative colitis (uc), inflammatory bowel disease (ibd), colitis, ulcerative colitis, inflammatory bowel disease, microbiome, gut microbiota, fecal calprotectin, artificial intelligence, partial mayo score, 5-asa, mesalamine
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 829028
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.